Logo

Quidel

Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates

Quidel CEO Douglas Bryant said the firm's base business grew 24 percent year over year, excluding COVID and influenza products.

Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business

The firms have agreed to transition the business to Beckman, with Quidel receiving annual payments until 2029.

OraSure Stock Ticks Up on Rumor of Declined Quidel Acquisition Offer

The firm's stock price rose as much as nearly 12 percent on Monday following a report saying that it had rejected a takeover bid from Quidel.

Quidel Nabs CE Mark for Savanna Analyzer, Respiratory Panel

The new instrument can analyze up to 12 pathogens from a single sample, while the respiratory panel detects influenza A and B, RSV, and COVID-19.

Quidel Recalls Lyra SARS-CoV-2 Test Due to Potential False Negative Results

The assay is being recalled due to a significant risk of false negative results for patients with relatively high amounts of SARS‐CoV‐2 virus.

Jun 1, 2021

GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April

Apr 23, 2021

Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations

Mar 10, 2021

Quidel Guides for Revenues Below Street Estimate, Citing Softening SARS-CoV-2 Test Demand

Mar 2, 2021

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

Feb 19, 2021

Quidel Reports Delay in OTC COVID-19 Antigen Test Claims, Pours Cold Water on M&A Rumors
Premium

Feb 18, 2021

Quidel Q4 Revenues Increase Sharply on COVID-19 Sales, Beat EPS Estimates

Feb 1, 2021

Fulgent Genetics Soars in January as GenomeWeb Index Begins 2021 up 10 Percent

Jan 13, 2021

At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

Jan 7, 2021

Quidel Preliminary Q4 Revenues Up Fivefold

Dec 23, 2020

Quidel Gets EUA for Rapid, Extraction-Free COVID-19 MDx on Solana System

Dec 1, 2020

Veracyte, Twist Bioscience Lead November GenomeWeb Index on Strong Earnings Growth

Oct 30, 2020

Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond'
Premium

Oct 29, 2020

Quidel Q3 Revenues More Than Triple, Beat Analyst Expectations

Oct 1, 2020

Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance

Sep 18, 2020

People in the News: New Appointments at Quidel, NeoGenomics, Veracyte, More

Sep 8, 2020

As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza
Premium

Sep 1, 2020

Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent

Aug 27, 2020

As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit

Aug 4, 2020

GenomeWeb Index Up 13 Percent in July as Investors Cheer COVID Dx Development

Jul 31, 2020

Facing 'Unfathomable' Demand, Quidel Ramps Up SARS-CoV-2 Test Production
Premium

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.